Evolv Board Member Mark Sullivan Gets Annual Stock Compensation Package

Rhea-AI Filing Summary

Director Mark J. Sullivan of Evolv Technologies Holdings (EVLV) received a grant of 27,050 Restricted Stock Units (RSUs) on June 20, 2025. Each RSU represents the right to receive one share of Class A common stock.

Key terms of the RSU grant:

• The RSUs will fully vest on the earlier of June 20, 2026 or the day before the next annual meeting
• The RSUs were granted at no cost ($0)
• The securities are held in direct ownership
• The RSUs have no expiration date

This Form 4 filing was submitted by Rachel Roy as attorney-in-fact for Mark Sullivan on June 24, 2025, within the required reporting window for insider transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sullivan Mark J.

(Last) (First) (Middle)

C/O EVOLV TECHNOLOGIES HOLDINGS, INC

500 TOTTEN POND ROAD, 4TH FLOOR

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Evolv Technologies Holdings, Inc. [ EVLV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	06/20/2025		A		27,050		(2)	(1)	Class A Common Stock	27,050	$0	27,050	D

Explanation of Responses:

1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date.

2. The RSUs will vest in full at the earlier of June 20, 2026 or the day immediately preceding the Issuer's next annual meeting date.

Remarks:

	/s/ Rachel Roy, Attorney-in-fact for Mark Sullivan	06/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Restricted Stock Units (RSUs) did EVLV director Mark Sullivan receive on June 20, 2025?

Mark Sullivan received 27,050 Restricted Stock Units (RSUs) of EVLV on June 20, 2025, with each RSU representing a contingent right to receive one share of the company's Class A common stock.

When will Mark Sullivan's EVLV RSUs vest?

The RSUs will vest in full at the earlier of either June 20, 2026, or the day immediately preceding EVLV's next annual meeting date.

What was the purchase price of the RSUs granted to EVLV director Mark Sullivan?

The RSUs were granted at a price of $0, as indicated in the Form 4 filing under the 'Price of Derivative Security' column.

What position does Mark Sullivan hold at EVLV according to the Form 4?

According to the Form 4 filing, Mark Sullivan serves as a Director of Evolv Technologies Holdings, Inc. (EVLV), as indicated by the 'X' marked in the Director box under the Relationship of Reporting Person(s) to Issuer section.

Who signed the Form 4 filing for EVLV director Mark Sullivan?

The Form 4 was signed by Rachel Roy, serving as Attorney-in-fact for Mark Sullivan, on June 24, 2025.